M. Komatsubara

Utilization of a three-dimensional printed kidney model for favorable TRIFECTA achievement in early experience of robot-assisted partial nephrectomy

T. Sugihara, T. Fujimura, A. Fujisaki, 2020, Translational andrology and urology.

Sunitinib versus sorafenib for patients with advanced renal cell carcinoma with renal impairment before the immune-oncology therapy era.

T. Sugihara, T. Fujimura, A. Fujisaki, 2019, Japanese journal of clinical oncology.

Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer

T. Morita, Kenji Komatsu, Y. Nagao, 2017, The Journal of Steroid Biochemistry and Molecular Biology.

Tumor Thrombus of Renal Cell Carcinoma Extending Into the Inferior Vena Cava, Ovarian Vein, and Ureter Treated With Neoadjuvant Axitinib.

T. Morita, A. Fujisaki, S. Kurokawa, 2016, Urology.

Treatment outcome of radium-223 treatment for castration-resistant prostate cancer and bone metastases at a single university hospital

A. Fujisaki, J. Kamei, S. Ando, 2022, International Journal of Radiation Research.

Panoramic laparoscopic view of transverse testicular ectopia.

T. Morita, M. Komatsubara, Tomohiro Kameda, 2015, Urology.

The efficacy of axitinib as a first‐line treatment for metastatic renal cell carcinoma

T. Sugihara, T. Fujimura, A. Fujisaki, 2020, Asia-Pacific journal of clinical oncology.